Dr. Takeki Suzuki, assistant professor in the Division of Cardiovascular Diseases, was awarded funding as Principal Investigator for an ongoing project in collaboration with the National Institutes of Health and Mayo Clinic entitled “Shared Decision Making for AFib study (SDM4Afib).” SDM4Afib is a multicenter encounter-level randomized controlled trial with 5 centers in the U.S. The trial will test a novel shared-decision making tool to facilitate conversations with patients regarding anticoagulation for non-valvular atrial fibrillation. Shared-decision making (SDM) in stroke prevention is an important aspect in patients with atrial fibrillation (AFib). The shared decision making tool was created by Mayo clinic (https://anticoagulationdecisionaid.mayoclinic.org/) and the primary outcome to be assessed will be the quality of SDM as perceived by participants comparing the SDM4Afib tool vs control (conventional).
This study is open to enrollment at UMMC. Says Suzuki, “We are happy to be part of the study investigating on the very important aspect in AFib management.” Research coordinators for this study are Memrie Price and Theresa Hutson. If interested in the study, please contact Dr. Suzuki at email@example.com.